Close

Analyst Ratings for Elevation Oncology (ELEV)

ELEV Rating Summary

ELEV Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ELEV
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $7.25 (+41.3%) * Over Last 12-Mos
Rating Score: 8.3 / 10   Percentile Rank: 86%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/1/2024 JMP Securities Silvan Tuerkcan New Coverage Market Outperform
(N/A)
7.00
(N/A)
3.85
(5.13)
33.25% Details
9/29/2023 H.C. Wainwright
» Updated 2/20/2024
Swayampakula Ramakanth New Coverage Buy
(N/A)
6.00
(1.50)
0.68
(5.13)
654.41% Details
Like ELEV Ratings? Also take a look at NKTX, AMAM, ONCY, AMGN

ELEV Ratings News